{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:35:05Z","timestamp":1772825705560,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Hospitals Authority\u2019 Ascent Plan","award":["DFL20191401"],"award-info":[{"award-number":["DFL20191401"]}]},{"name":"Beijing Hospitals Authority\u2019 Ascent Plan","award":["DFL20191401"],"award-info":[{"award-number":["DFL20191401"]}]},{"name":"Beijing Hospitals Authority\u2019 Ascent Plan","award":["DFL20191401"],"award-info":[{"award-number":["DFL20191401"]}]},{"name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development","award":["ZYLX201830"],"award-info":[{"award-number":["ZYLX201830"]}]},{"name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development","award":["ZYLX201830"],"award-info":[{"award-number":["ZYLX201830"]}]},{"name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development","award":["ZYLX201830"],"award-info":[{"award-number":["ZYLX201830"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The appearance of malignancies at various times in the same individual, excluding metastases of the initial primary cancer, is termed multiple primary cancers. Double primary gynecological cancers cause inevitable damage to female reproductive function, and the preservation of fertility in such patients remains a challenging issue as relatively few cases have been reported. This case report provides management options for dual primary ovarian and endometrial cancers, including the choice of ovulation induction protocols, considerations during pregnancy and parturition, with the aim of providing assistance to clinicians.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report a case of a 39-year-old woman with primary infertility and a medical history of right-sided ovarian mucinous borderline tumor with intraepithelial carcinoma, left-sided ovarian mucinous cystadenoma and endometrial cancer, who successfully conceived with in vitro fertilization-embryo transfer (IVF-ET) after three different ovulation induction protocols. During her pregnancy, she was complicated by central placenta praevia with placental implantation and eventually delivered a healthy female infant by caesarean section at 33 gestational weeks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>For patients with double primary gynecological cancers who have an intense desire for fertility,  the most appropriate oncological treatment should be applied according to the patient\u2019s individual situation, and fertility preservation should be performed promptly. Ovulation induction protocol should be individualized and deliberate, with the aim of ensuring that the patient\u2019s hormone levels do not precipitate a recurrence of the primary disease during induction of ovulation and maximizing fertility outcomes. In addition, the risk of postpartum hemorrhage due to placental factors cannot be neglected in such patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-023-05973-z","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T11:02:06Z","timestamp":1695121326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Successful delivery after in vitro fertilization-embryo transfer in a woman with metachronous primary cancer of ovary and endometrium: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Yichang","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaokui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"issue":"2","key":"5973_CR1","doi-asserted-by":"publisher","first-page":"e000172","DOI":"10.1136\/esmoopen-2017-000172","volume":"2","author":"A Vogt","year":"2017","unstructured":"Vogt A, Schmid S, Heinimann K, Frick H, Herrmann C, Cerny T, Omlin A. Multiple primary tumours: challenges and approaches, a review. ESMO Open. 2017;2(2):e000172.","journal-title":"ESMO Open"},{"issue":"3","key":"5973_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"5973_CR3","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1158\/1055-9965.EPI-06-0782","volume":"16","author":"AB Mariotto","year":"2007","unstructured":"Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev. 2007;16(3):566\u201371.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5973_CR4","doi-asserted-by":"publisher","first-page":"e8316","DOI":"10.7717\/peerj.8316","volume":"8","author":"J Xiong","year":"2020","unstructured":"Xiong J, Su Y, Bing Z, Zhao B. Survival between synchronous and non-synchronous multiple primary cutaneous melanomas-a SEER database analysis. PeerJ. 2020;8:e8316.","journal-title":"PeerJ"},{"issue":"1","key":"5973_CR5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1186\/s12885-021-08766-9","volume":"21","author":"P Tanjak","year":"2021","unstructured":"Tanjak P, Suktitipat B, Vorasan N, Juengwiwattanakitti P, Thiengtrong B, Songjang C, Therasakvichya S, Laiteerapong S, Chinswangwatanakul V. Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study. BMC Cancer. 2021;21(1):1045.","journal-title":"BMC Cancer"},{"issue":"May 14","key":"5973_CR6","first-page":"1329","volume":"76","author":"L Owen","year":"1921","unstructured":"Owen L. Multiple malignant neoplasms. JAMA. 1921;76(May 14):1329.","journal-title":"JAMA"},{"issue":"1","key":"5973_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00000421-200302000-00015","volume":"26","author":"CG Demandante","year":"2003","unstructured":"Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol. 2003;26(1):79\u201383.","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"5973_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.soncn.2014.11.006","volume":"31","author":"P Patterson","year":"2015","unstructured":"Patterson P, McDonald FE, Zebrack B, Medlow S. Emerging issues among adolescent and young adult cancer survivors. Semin Oncol Nurs. 2015;31(1):53\u20139.","journal-title":"Semin Oncol Nurs"},{"issue":"6","key":"5973_CR9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/00000478-199906000-00001","volume":"23","author":"MA Riopel","year":"1999","unstructured":"Riopel MA, Ronnett BM, Kurman RJ. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol. 1999;23(6):617\u201335.","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 3","key":"5973_CR10","first-page":"227","volume":"24","author":"T Batool","year":"2014","unstructured":"Batool T, Ullah NR. Mucinous borderline ovarian tumor with ascites. J Coll Physicians Surg Pak. 2014;24(Suppl 3):227\u20139.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"4","key":"5973_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/jog.14210","volume":"46","author":"RF Chen","year":"2020","unstructured":"Chen RF, Tao X, Wu BB, Li J, Wang JY, Gu WY, Lu X. Mucinous borderline ovarian tumors with and without Intraepithelial Carcinoma: differences in clinicopathologic features and fertility results. J Obstet Gynaecol Res. 2020;46(4):646\u201353.","journal-title":"J Obstet Gynaecol Res"},{"key":"5973_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13048-016-0226-y","volume":"9","author":"RF Chen","year":"2016","unstructured":"Chen RF, Li J, Zhu TT, Yu HL, Lu X. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience. J Ovarian Res. 2016;9:16.","journal-title":"J Ovarian Res"},{"issue":"1","key":"5973_CR13","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1186\/s12885-018-4932-2","volume":"18","author":"C Fang","year":"2018","unstructured":"Fang C, Zhao L, Chen X, Yu A, Xia L, Zhang P. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (\u2264 40 years old) with borderline ovarian tumors. BMC Cancer. 2018;18(1):1147.","journal-title":"BMC Cancer"},{"issue":"6","key":"5973_CR14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/bjc.2016.254","volume":"115","author":"R Fruscio","year":"2016","unstructured":"Fruscio R, Ceppi L, Corso S, Galli F, Dell\u2019Anna T, Dell\u2019Orto F, Giuliani D, Garbi A, Chiari S, Mangioni C, et al. Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer. Br J Cancer. 2016;115(6):641\u20138.","journal-title":"Br J Cancer"},{"issue":"4","key":"5973_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ejso.2013.11.028","volume":"40","author":"I Zapardiel","year":"2014","unstructured":"Zapardiel I, Diestro MD, Aletti G. Conservative treatment of early stage ovarian cancer: oncological and fertility outcomes. Eur J Surg Oncol. 2014;40(4):387\u201393.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"5973_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1472-6483(10)60204-0","volume":"17","author":"E Porcu","year":"2008","unstructured":"Porcu E, Venturoli S, Damiano G, Ciotti PM, Notarangelo L, Paradisi R, Moscarini M, Ambrosini G. Healthy twins delivered after oocyte cryopreservation and bilateral ovariectomy for ovarian cancer. Reprod Biomed Online. 2008;17(2):265\u20137.","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"5973_CR17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.rbmo.2014.02.010","volume":"28","author":"M Alvarez","year":"2014","unstructured":"Alvarez M, Sol\u00e9 M, Devesa M, F\u00e1bregas R, Boada M, Tur R, Coroleu B, Veiga A, Barri PN. Live birth using vitrified\u2013warmed oocytes in invasive ovarian cancer: case report and literature review. Reprod Biomed Online. 2014;28(6):663\u20138.","journal-title":"Reprod Biomed Online"},{"key":"5973_CR18","doi-asserted-by":"crossref","unstructured":"Porcu E, Cipriani L, Dirodi M, De Iaco P, Perrone AM, Zinzani PL, Taffurelli M, Zamagni C, Ciotti PM, Notarangelo L et al. Successful pregnancies, births, and Children Development following oocyte cryostorage in Female Cancer Patients during 25 years of Fertility Preservation. Cancers (Basel) 2022, 14(6).","DOI":"10.3390\/cancers14061429"},{"issue":"2","key":"5973_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/humupd\/dms047","volume":"19","author":"E Dara\u00ef","year":"2013","unstructured":"Dara\u00ef E, Fauvet R, Uzan C, Gouy S, Duvillard P, Morice P. Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update. 2013;19(2):151\u201366.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"5973_CR20","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s10815-020-01733-6","volume":"37","author":"F Filippi","year":"2020","unstructured":"Filippi F, Martinelli F, Somigliana E, Franchi D, Raspagliesi F, Chiappa V. Oocyte cryopreservation in two women with borderline ovarian tumor recurrence. J Assist Reprod Genet. 2020;37(5):1213\u20136.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"5973_CR21","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.ygyno.2021.04.017","volume":"161","author":"SM Lucchini","year":"2021","unstructured":"Lucchini SM, Esteban A, Nigra MA, Palacios AT, Alzate-Granados JP, Borla HF. Updates on conservative management of endometrial cancer in patients younger than 45 years. Gynecol Oncol. 2021;161(3):802\u20139.","journal-title":"Gynecol Oncol"},{"key":"5973_CR22","first-page":"691","volume":"6","author":"E Kalogera","year":"2014","unstructured":"Kalogera E, Dowdy SC, Bakkum-Gamez JN. Preserving fertility in young patients with endometrial cancer: current perspectives. Int J Womens Health. 2014;6:691\u2013701.","journal-title":"Int J Womens Health"},{"issue":"2","key":"5973_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/IGC.0000000000001164","volume":"28","author":"Z Fan","year":"2018","unstructured":"Fan Z, Li H, Hu R, Liu Y, Liu X, Gu L. Fertility-preserving treatment in Young Women with Grade 1 presumed Stage IA Endometrial Adenocarcinoma: a Meta-analysis. Int J Gynecol Cancer. 2018;28(2):385\u201393.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"5973_CR24","doi-asserted-by":"publisher","first-page":"266e261","DOI":"10.1016\/j.ajog.2012.08.011","volume":"207","author":"ID Gallos","year":"2012","unstructured":"Gallos ID, Yap J, Rajkhowa M, Luesley DM, Coomarasamy A, Gupta JK. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol. 2012;207(4):266e261\u2013212.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"5973_CR25","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s10815-022-02475-3","volume":"39","author":"Y Guo","year":"2022","unstructured":"Guo Y, Zong X, Li H, Qiao J. Analysis of IVF\/ICSI outcomes in infertile women with early-stage endometrial cancer and atypical endometrial hyperplasia after conservative treatment. J Assist Reprod Genet. 2022;39(7):1643\u201351.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"5973_CR26","first-page":"211","volume":"23","author":"N Massin","year":"2017","unstructured":"Massin N. New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF. Hum Reprod Update. 2017;23(2):211\u201320.","journal-title":"Hum Reprod Update"},{"key":"5973_CR27","doi-asserted-by":"publisher","first-page":"581927","DOI":"10.3389\/fmed.2021.581927","volume":"8","author":"J Chen","year":"2021","unstructured":"Chen J, Cheng Y, Fu W, Peng X, Sun X, Chen H, Chen X, Yu M. PPOS Protocol effectively improves the IVF Outcome without increasing the recurrence rate in early endometrioid endometrial Cancer and atypical endometrial hyperplasia patients after fertility preserving treatment. Front Med (Lausanne). 2021;8:581927.","journal-title":"Front Med (Lausanne)"},{"key":"5973_CR28","doi-asserted-by":"publisher","first-page":"676133","DOI":"10.3389\/fendo.2021.676133","volume":"12","author":"AM Yang","year":"2021","unstructured":"Yang AM, Cui N, Sun YF, Hao GM. Letrozole for female infertility. Front Endocrinol (Lausanne). 2021;12:676133.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"5973_CR29","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1136\/ijgc-2019-001128","volume":"30","author":"C Marchetti","year":"2020","unstructured":"Marchetti C, De Felice F, Ergasti R, Scambia G, Fagotti A. Letrozole in the management of advanced ovarian cancer: an old drug as a new targeted therapy. Int J Gynecol Cancer. 2020;30(7):1058\u201364.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"5973_CR30","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.rbmo.2020.11.018","volume":"42","author":"HG Herman","year":"2021","unstructured":"Herman HG, Mizrachi Y, Farhadian Y, Alon AS, Gluck O, Bar J, Kovo M, Raziel A. Placental disorders of pregnancy in subsequent IVF pregnancies\u2013a sibling cohort. Reprod Biomed Online. 2021;42(3):620\u20136.","journal-title":"Reprod Biomed Online"},{"key":"5973_CR31","doi-asserted-by":"crossref","unstructured":"Nishio S, Takeno T, Fukuda T, Shikama A, Nakai H, Nakamura H, Tokunaga H, Takahashi K, Okuma E, Mori M et al. Outcomes of Pregnancies and Deliveries of Patients Who Underwent Fertility-Preserving Surgery for Early-Stage Epithelial Ovarian Cancer. J Clin Med 2022, 11(18).","DOI":"10.3390\/jcm11185346"},{"issue":"4","key":"5973_CR32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s10147-023-02297-y","volume":"28","author":"M Oishi","year":"2023","unstructured":"Oishi M, Kasuga Y, Fukuma Y, Hamuro A, Tamai J, Tanaka Y, Hasegawa K, Yoshimura T, Ikenoue S, Ochiai D, et al. Obstetric outcomes after medroxyprogesterone acetate treatment for early stage endometrial cancer or atypical endometrial hyperplasia: a single hospital-based study. Int J Clin Oncol. 2023;28(4):587\u201391.","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"5973_CR33","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/AOG.0000000000001005","volume":"126","author":"RM Silver","year":"2015","unstructured":"Silver RM. Abnormal placentation: Placenta Previa, Vasa Previa, and Placenta Accreta. Obstet Gynecol. 2015;126(3):654\u201368.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"5973_CR34","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1080\/14767058.2020.1771690","volume":"35","author":"PI Cavoretto","year":"2022","unstructured":"Cavoretto PI, Giorgione V, Sotiriadis A, Vigan\u00f2 P, Papaleo E, Galdini A, Gaeta G, Candiani M. IVF\/ICSI treatment and the risk of iatrogenic preterm birth in singleton pregnancies: systematic review and meta-analysis of cohort studies. J Matern Fetal Neonatal Med. 2022;35(10):1987\u201396.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"5973_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/humupd\/dmx031","volume":"24","author":"A Maheshwari","year":"2018","unstructured":"Maheshwari A, Pandey S, Amalraj Raja E, Shetty A, Hamilton M, Bhattacharya S. Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer? Hum Reprod Update. 2018;24(1):35\u201358.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"5973_CR36","doi-asserted-by":"publisher","first-page":"126e121","DOI":"10.1016\/j.ajog.2019.03.010","volume":"221","author":"GE Ginstr\u00f6m Ernstad","year":"2019","unstructured":"Ginstr\u00f6m Ernstad GE, Wennerholm UB, Khatibi A, Petzold M, Bergh C. Neonatal and maternal outcome after frozen embryo transfer: increased risks in programmed cycles. Am J Obstet Gynecol. 2019;221(2):126e121\u2013126e118.","journal-title":"Am J Obstet Gynecol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-05973-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-023-05973-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-05973-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T12:17:54Z","timestamp":1700482674000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-023-05973-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5973"],"URL":"https:\/\/doi.org\/10.1186\/s12884-023-05973-z","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"assertion":[{"value":"7 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was provided from the patient for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"677"}}